All-cause pneumonia in children after the introduction of pneumococcal vaccines in the United Kingdom: A population-based study.
Wallis C Y LauJulia Anna BielickiChiara TersigniSonia SaxenaIan Chi Kei Ck WongMichael SharlandYingfen HsiaPublished in: Pharmacoepidemiology and drug safety (2019)
In the United Kingdom, the incidence of all-cause pneumonia in children under 2 years declined after the introduction of PCV7 and levelled off in the first 2 years of introduction of PCV13. Continual monitoring is warranted to assess the population impact of PCV13 in preventing childhood pneumonia in the long term.